GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Cross Corp (XKRX:006280) » Definitions » Median PS Value

Green Cross (XKRX:006280) Median PS Value : ₩216,288.71 (As of Apr. 29, 2025)


View and export this data going back to 1989. Start your Free Trial

What is Green Cross Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Green Cross's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was ₩147065.144. Green Cross's 10-Year median PS Ratio is 1.4707. Therefore, the Median PS Value for today is ₩216,288.71.

As of today (2025-04-29), Green Cross's share price is ₩123500.00. Green Cross's Median PS Value is ₩216,288.71. Therefore, Green Cross's Price to Median PS Value for today is 0.57.

The historical rank and industry rank for Green Cross's Median PS Value or its related term are showing as below:

XKRX:006280' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.51   Med: 0.75   Max: 1.79
Current: 0.57

During the past 13 years, the highest Price to Median PS Value of Green Cross was 1.79. The lowest was 0.51. And the median was 0.75.

XKRX:006280's Price-to-Median-PS-Value is ranked better than
75.42% of 533 companies
in the Drug Manufacturers industry
Industry Median: 0.83 vs XKRX:006280: 0.57

Green Cross Median PS Value Historical Data

The historical data trend for Green Cross's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Cross Median PS Value Chart

Green Cross Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 227,244.13 232,628.14 252,346.59 229,838.19 216,288.71

Green Cross Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 229,838.19 226,401.48 223,589.98 220,070.20 216,288.71

Competitive Comparison of Green Cross's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, Green Cross's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Green Cross's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Green Cross's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Green Cross's Price-to-Median-PS-Value falls into.


;
;

Green Cross Median PS Value Calculation

Green Cross's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=147065.144*1.4707
=216,288.71

10-Year Median PS Ratio is 1.4707.
Green Cross's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩147065.144.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Green Cross  (XKRX:006280) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Green Cross's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=123500.00/216,288.71
=0.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Green Cross Median PS Value Related Terms

Thank you for viewing the detailed overview of Green Cross's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Green Cross Business Description

Traded in Other Exchanges
N/A
Address
303 Bojeong-Dong, Giheung-Gu, Yongin, Gyeonggi, KOR, 449-070
Green Cross Corp is one of the global leaders in the healthcare sector. The Montreal-based biopharmaceutical company primarily develops intravenous immunoglobulin (IVIG), a key therapeutic solution for the treatment of patients with infectious and immune diseases, and albumin, used as a blood-volumizing agent and in the treatment of burns. Currently, the company has a global presence through its association with various subsidiaries.

Green Cross Headlines

No Headlines